Table 1. Demographic and clinical data for the subjects with angina and healthy men.
| Angina | Healthy men | P value | |
|---|---|---|---|
| (n = 240) | (n = 26) | ||
| Age | 60±12 | 39±10 | < 0.001 |
| Gender (M/F) | 197/43 | 26/0 | 0.011 |
| BMI (kg/m2) | 26.2±3.8 | 22.4±1.5 | < 0.001 |
| WC (cm) | 91.0±9.1 | 82.0±6.2 | < 0.001 |
| SBP (mmHg) | 127±18 | 114±10 | < 0.001 |
| DBP (mmHg) | 74±10 | 68±7 | 0.015 |
| Total cholesterol (mmol/L) | 4.61±0.98 | 4.84±0.83 | 0.291 |
| Triglycerides (mmol/L) | 1.57±0.89 | 1.08±0.36 | < 0.001 |
| HDL cholesterol (mmol/L) | 1.22±0.26 | 1.42±0.31 | < 0.001 |
| LDL cholesterol (mmol/L) | 2.62±0.78 | 3.03±0.76 | 0.015 |
| OGTT0’ (mmol/L) | 5.33±0.78 | 4.99±0.39 | 0.039 |
| OGTT120’ (mmol/L) | 8.10±2.49 | 6.38±1.83 | < 0.001 |
| HbA1c (%) | 5.9±0.5 | ||
| GPT (U/L)* | 31±36 | 25±12 | 0.383 |
| Creatinine (umol/L) | 85.7±25.6 | 78.6±10.6 | 0.006 |
| Hs-CRP (mg/L)* | 1.82±1.96 | 1.81±4.2 | 0.962 |
| SYNTAX score | 10.0±15.6 | ||
| Jeopardy score | 3.3±3.9 | ||
| Medications | |||
| Antiplatelet, % | 95 | ||
| ACEI/ARB, % | 52.1 | ||
| β-blockers, % | 28.3 | ||
| CCB, % | 50.8 | ||
| Statins, % | 52.5 | ||
| Family history | |||
| DM (father), n | 25 | ||
| DM (mother), n | 45 | ||
| CAD (father), n | 38 | ||
| CAD (mother), n | 34 |
BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; HDL: high-density lipoprotein; LDL: low-density lipoprotein; OGTT 0’: glucose before 75-g oral glucose challenge test; OGTT 120’: glucose at 120 minutes after 75-g oral glucose challenge test; GPT: glutamic pyruvic transaminase; HbA1c: hemoglobin A1c; Hs-CRP: high-sensitivity C-reactive protein; ACEI: angiotensin-converting enzyme; ARB: angiotensin II receptor antagonist; CCB: calcium channel blocker; DM: diabetes mellitus; CAD: coronary artery disease
*P-value between groups based on the non-parametric Mann-Whitney test.